AutoloGel^™ Platelet Rich Plasma Receives Marketing Clearance

       Cytomedix Inc (Rockville, Md) received US Food and Drug Administration (FDA) marketing clearance for its AutoloGel^™ System. AutoloGel is currently the only autologous platelet gel therapy product with FDA clearance. Cytomedix is the first company in the US to complete a randomized, controlled, multi-center, double-blinded, clinical trial for a platelet rich plasma (PRP) gel system that aids in wound healing.
       Visit http://www.cytomedix.com for more information.

Silhouette^™ Wound Documentation System Receives FDA Pre-market Clearance

       Aranz Medical Limited (Christchurch, New Zealand ) announced that the Silhouette^™, a computerized wound imaging, analysis, and documentation system, recently received 510(k) pre-market clearance from the US Food and Drug Administration (FDA).
       The system uses a customdesigned camera, which accurately relays quantitative information to an electronic patient record for printing, electronic distribution, and archiving.
       Visit http://www.aranzmedical.com for more information.